The supplement question Certain supplements that supported your tirzepatide regimen may continue to provide value during and after tapering
Neither drug should be used in people that have a medical history of the following: Heart disease Treatment with an MAOI currently or within the past 14 days Hyperthyroidism Agitation Substance use disorder Glaucoma Currently pregnant or breastfeeding Allergies to the medication Pulmonary hypertension (high blood pressure in the lungs) and valvular heart disease have been reported in people taking phendimetrazine or phentermine
Only studies published from 1 May 2022, onward were considered, corresponding to the timing of FDA approval of tirzepatide ( 2.2 Inclusion and exclusion criteria Studies that met the eligibility criteria were marked for inclusion: Population: Adults (18 years) who are SOT (kidney, liver, heart, lung, pancreas or combined), in the post-transplant period
One study measuring skeletal muscle mass in older adults (aged 55 - 70) showed that taking a supplement containing L-Carnitine (1500 mg), L-leucine (2000 mg), creatine (3000 mg), and Vitamin D3 (10 g) for 8 weeks showed a 1.0 kg increase in total lean muscle mass (14)